These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2477207)

  • 1. [A preliminary study on oral flecainide acetate in treating tachyarrhythmias].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Apr; 17(2):107-10. PubMed ID: 2477207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-invasive evaluation of the effectiveness of flecainide in the treatment of ventricular extrasystole arrhythmia].
    Mangini SG; Mastropasqua F; Lagioia R; Ricci A; Scrutinio D; Rizzon P
    Cardiologia; 1986 Jun; 31(6):443-51. PubMed ID: 2434229
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral flecainide for the treatment of drug-resistant ventricular ectopy.
    Strasberg B; Stein S; Sclarovsky S
    Isr J Med Sci; 1990 May; 26(5):258-61. PubMed ID: 1696248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide: a new antiarrhythmic agent.
    Nestico PF; Morganroth J
    Am Fam Physician; 1986 Nov; 34(5):197-200. PubMed ID: 2430440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the anti-arrhythmia effect of flecainide acetate and prajmalium bitartrate in patients with tachycardiac ventricular rhythm disorders].
    Andresen D; von Leitner ER; Wegscheider K; Theiss A; Agena H; Schröder R
    Z Kardiol; 1986 Jul; 75(7):394-401. PubMed ID: 2429466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiological changes of the excitoconduction system in patients with Chagas cardiomyopathy and their modification by flecainide].
    Abitbol HF; Carrizo Paez R; Derlis Abate C
    Arch Inst Cardiol Mex; 1988; 58(2):107-14. PubMed ID: 2456750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy].
    Rosenbaum M; Posse R; Sgammini H; Núñez Burgos J; Chiale PA; Pastori JD; González Zuelgaray J; Brunetto JF; Califano JE
    Arch Inst Cardiol Mex; 1987; 57(4):325-30. PubMed ID: 2445316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of oral flecainide treatment of refractory tachyarrhythmias].
    Sakurada H; Hiyoshi Y; Tejima T; Yanase O; Tokuyasu Y; Watanabe K; Motomiya T; Sugiura M; Hiraoka M
    Kokyu To Junkan; 1990 May; 38(5):471-6. PubMed ID: 2115193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Caution in therapy of ventricular extrasystole. Staying safe with electrolytes].
    MMW Fortschr Med; 2002 Aug; 144(33-34):62. PubMed ID: 12380159
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When should ventricular extrasystole be treated?].
    Hoffmann A
    Schweiz Rundsch Med Prax; 1985 Jan; 74(1-2):1-2. PubMed ID: 2578687
    [No Abstract]   [Full Text] [Related]  

  • 13. Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.
    van Wijk LM; Crijns HJ; Kingma HJ; van Gilst WH; van Gelder IC; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):884-91. PubMed ID: 1694910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy with flecainide].
    Bramann HU; Bender F; Jachmann H; Grosse-Heitmeyer W
    Z Kardiol; 1984 Nov; 73(11):724-31. PubMed ID: 6084367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postinfarct ventricular extrasystole and the use of anti-arrhythmic drugs: a danger anticipated by electrophysiologists].
    Farré J; Brugada P
    Rev Esp Cardiol; 1989 Oct; 42(8):498-500. PubMed ID: 2481326
    [No Abstract]   [Full Text] [Related]  

  • 16. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].
    Liard F; Le Heuzey JY; Jaillon P; Lièvre M; Danchin N
    Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):113-22. PubMed ID: 16792025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intramuscular lidocaine in the treatment of ventricular extrasystole].
    Shapiro M; Paredes A; Guadalajara JF
    Arch Inst Cardiol Mex; 1972; 42(6):908-19. PubMed ID: 4119238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.